1577 related articles for article (PubMed ID: 23635920)
21. Improving Door-to-Needle Times for Acute Ischemic Stroke: Effect of Rapid Patient Registration, Moving Directly to Computed Tomography, and Giving Alteplase at the Computed Tomography Scanner.
Kamal N; Holodinsky JK; Stephenson C; Kashayp D; Demchuk AM; Hill MD; Vilneff RL; Bugbee E; Zerna C; Newcommon N; Lang E; Knox D; Smith EE
Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096208
[TBL] [Abstract][Full Text] [Related]
22. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
23. Delayed Intravenous Thrombolysis in Patients with Minor Stroke.
Yoo J; Sohn SI; Kim J; Ahn SH; Lee K; Baek JH; Kim K; Hong JH; Koo J; Kim YD; Kwak J; Nam HS; Heo JH
Cerebrovasc Dis; 2018; 46(1-2):52-58. PubMed ID: 30092583
[TBL] [Abstract][Full Text] [Related]
24. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
[TBL] [Abstract][Full Text] [Related]
25. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.
Lin CB; Peterson ED; Smith EE; Saver JL; Liang L; Xian Y; Olson DM; Shah BR; Hernandez AF; Schwamm LH; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):514-22. PubMed ID: 22787065
[TBL] [Abstract][Full Text] [Related]
26. Does a 'code stroke' rapid access protocol decrease door-to-needle time for thrombolysis?
Tai YJ; Weir L; Hand P; Davis S; Yan B
Intern Med J; 2012 Dec; 42(12):1316-24. PubMed ID: 22212180
[TBL] [Abstract][Full Text] [Related]
27. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017.
Tong X; Wiltz JL; George MG; Odom EC; Coleman King SM; Chang T; Yin X; ; Merritt RK
Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004981. PubMed ID: 30557047
[TBL] [Abstract][Full Text] [Related]
28. Intra-arterial therapy for acute ischemic stroke under general anesthesia versus monitored anesthesia care.
John S; Thebo U; Gomes J; Saqqur M; Farag E; Xu J; Wisco D; Uchino K; Hussain MS
Cerebrovasc Dis; 2014; 38(4):262-7. PubMed ID: 25401730
[TBL] [Abstract][Full Text] [Related]
29. Improvement in Door-to-Needle Time in Patients with Acute Ischemic Stroke via a Simple Stroke Activation Protocol.
Tan BYQ; Ngiam NJH; Sunny S; Kong WY; Tam H; Sim TB; Leong BSH; Bhartendu C; Paliwal PR; Seet RCS; Chan BPL; Teoh HL; Sharma VK; Yeo LLL
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1539-1545. PubMed ID: 29422380
[TBL] [Abstract][Full Text] [Related]
30. Safety of a "drip and ship" intravenous thrombolysis protocol for patients with acute ischemic stroke.
Mansoor S; Zand R; Al-Wafai A; Wahba MN; Giraldo EA
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):969-71. PubMed ID: 22306381
[TBL] [Abstract][Full Text] [Related]
31. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D
Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482
[TBL] [Abstract][Full Text] [Related]
32. Direct access to a hospital offering intravenous thrombolysis therapy improves functional outcome of acute ischemic stroke patients.
Kim DH; Cha JK; Park HS; Choi JH; Kang MJ; Huh JT
J Clin Neurosci; 2014 Aug; 21(8):1428-32. PubMed ID: 24980628
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: initial experience of a community-based hospital in a developing country.
Muengtaweepongsa S; Dharmasaroja P; Kummark U
J Stroke Cerebrovasc Dis; 2012 Jan; 21(1):42-6. PubMed ID: 22225863
[TBL] [Abstract][Full Text] [Related]
34. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N;
Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853
[TBL] [Abstract][Full Text] [Related]
35. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
Pretnar Oblak J; Sabovic M; Frol S
J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
[TBL] [Abstract][Full Text] [Related]
36. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era.
Endo K; Koga M; Sakai N; Yamagami H; Furui E; Matsumoto Y; Shiokawa Y; Yoshimura S; Okada Y; Nakagawara J; Hyogo T; Hasegawa Y; Nagashima H; Fujinaka T; Hyodo A; Terada T; Toyoda K;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823
[TBL] [Abstract][Full Text] [Related]
37. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
[TBL] [Abstract][Full Text] [Related]
38. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
39. Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.
Tanaka K; Matsumoto S; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104305. PubMed ID: 31405791
[TBL] [Abstract][Full Text] [Related]
40. CT-based intravenous thrombolysis 3-4.5 hours after acute ischemic stroke in clinical practice.
Sarikaya H; Fischer A; Valko PO; Weck A; Braun J; Georgiadis D; Baumgartner RW
Neurol Res; 2011 Sep; 33(7):701-7. PubMed ID: 21756549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
